Targeting neuroinflammation: 3-monothiopomalidomide a new drug candidate to mitigate traumatic brain injury and neurodegeneration.

Saved in:
Bibliographic Details
Title: Targeting neuroinflammation: 3-monothiopomalidomide a new drug candidate to mitigate traumatic brain injury and neurodegeneration.
Authors: Hsueh, Shih Chang1 (AUTHOR), Parekh, Pathik1 (AUTHOR), Batsaikhan, Buyandelger1 (AUTHOR), Vargesson, Neil2 (AUTHOR), Tweedie, David1 (AUTHOR), Luo, Weiming1 (AUTHOR), Patel, Chirag N.1 (AUTHOR), Liu, Dong1 (AUTHOR), McDevitt, Ross A.3 (AUTHOR), Baig, Abdul Mannan4 (AUTHOR), Kim, Yu Kyung5 (AUTHOR), Kim, Sun5 (AUTHOR), Hwang, Inho5 (AUTHOR), Kim, Juwan5 (AUTHOR), Lee, Mee Youn5 (AUTHOR), Carta, Anna R.6 (AUTHOR), Selman, Warren R.7 (AUTHOR), Hoffer, Barry J.8 (AUTHOR), Kim, Dong Seok5,9 (AUTHOR), Greig, Nigel H.1 (AUTHOR) Greign@grc.nia.nih.gov
Source: Journal of Biomedical Science. 6/16/2025, Vol. 32 Issue 1, p1-29. 29p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:10217770
DOI:10.1186/s12929-025-01150-w